01—Abstract
Summary
Summary of the 10-Q filed January 23, 2020. Cited figures are marked; the original filing is the authoritative source.
Procter & Gamble (PG) reported strong financial results for the second quarter and first half of fiscal year 2020, demonstrating robust sales growth and improved profitability.
Net sales for the quarter increased by 5% to $18.24 billiona, and for the six-month period, sales grew 6% to $36.04 billion. This growth was driven by a combination of increased volume (3% for the quarter and 4% for the six-month period) and favorable pricing and mix across key segments. Profitability also saw significant improvements.
Operating income rose 15% for the quarter and 18% for the six-month period, with net earnings attributable to P&G increasing by 16% and 14%, respectively. Diluted Earnings Per Share (EPS) saw a corresponding increase of 16% for the quarter to $1.41b and 14% for the six-month period to $2.77.
The company also highlighted strong cash flow generation, with adjusted free cash flow of $7.1 billionc for the six months and an impressive adjusted free cash flow productivity of 96%. These results underscore P&G's ability to navigate market dynamics and execute its growth and productivity strategies effectively.
02—Key points
Key Highlights
- Net sales increased 5% to $18.24 billion for the three months ended December 31, 2019, and 6% to $36.04 billion for the six months ended December 31, 2019.
- Diluted EPS rose 16% to $1.41 for the three months and 14% to $2.77 for the six months, indicating strong bottom-line performance.
- Gross margin improved significantly, increasing by 250 basis points to 51.4% for the quarter and 220 basis points to 51.2% for the six months, driven by cost savings and pricing.
- Health Care segment showed robust growth, with net sales up 14% for the quarter and 17% for the six months, driven by strong volume increases.
- The company generated $8.5 billion in operating cash flow for the six-month period, demonstrating healthy cash generation capabilities.
- P&G actively returned capital to shareholders, repurchasing approximately $6.5 billion in treasury stock and paying dividends of $3.9 billion during the six-month period.
- Core EPS increased by 14% for the quarter and 18% for the six months, excluding certain charges, indicating underlying business strength.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2020, Procter & Gamble Co kept $0.20.
- Revenue$18.24B100.0%
- Cost of revenue−$8.87B48.6%
- Gross profit$9.37B51.4%
- Operating costs−$4.89B26.8%
- Operating income$4.48B24.6%
- Interest, other & tax−$765.0M4.2%
- Net income$3.72B20.4%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2020filed January 23, 2020Financial Statements
Q2 FY2020 against Q2 FY2019
| Line item | Q2 FY2020Q2 FY2019 | Change |
|---|---|---|
| Revenue | $18.24B$17.44B | +4.6% |
| Cost of Revenue | $8.87B$8.92B | −0.6% |
| Gross Profit | $9.37B$8.52B | +10.0% |
| SG&A Expenses | $4.89B$4.62B | +5.8% |
| Operating Income | $4.48B$3.90B | +15.0% |
| Interest Expense | $100.00M$138.00M | −27.5% |
| Net Income | $3.72B$3.19B | +16.4% |
| EPS (Basic) | $1.47$1.25 | +17.6% |
| EPS (Diluted) | $1.41$1.22 | +15.6% |
| Shares Outstanding (Basic) | 2.49B2.50B | −0.5% |
| Shares Outstanding (Diluted) | 2.63B2.62B | +0.3% |
05—Questions
Frequently Asked Questions
What were the main drivers of P&G's sales growth in this period?
Sales growth was driven by a combination of factors including a 3% increase in unit volume for the quarter and 4% for the six-month period, alongside favorable pricing (1% for the quarter, 1% for the six months) and product mix (1% for the quarter, 2% for the six months). The Health Care segment, in particular, saw strong volume growth, contributing significantly to the overall increase.
How did P&G's profitability change compared to the prior year?
Profitability improved significantly. Operating income increased by 15% for the quarter and 18% for the six months. Net earnings attributable to P&G rose by 16% for the quarter and 14% for the six months. This was supported by strong gross margin expansion due to manufacturing cost savings, lower commodity costs, and improved pricing, alongside effective SG&A management.
What is the company's approach to returning capital to shareholders?
P&G demonstrated a commitment to returning capital through significant share repurchases and dividend payments. For the six months ended December 31, 2019, the company used $6.5 billion for treasury stock purchases and $3.9 billion for dividends to shareholders, indicating a balanced approach to capital allocation.
Are there any significant risks or uncertainties mentioned that investors should be aware of?
The company highlighted several risks and uncertainties including global economic volatility, foreign exchange fluctuations, commodity price changes, competitive pressures, and regulatory changes. Specific risks like currency devaluation in certain markets and changes in consumer habits were also noted. Management continuously monitors these factors and implements strategies to mitigate their impact.
06—Continue